| S2799 | 
                                    
                                        
                                        
                                            Daporinad (FK866)
                                        
                                     | 
                                    Daporinad (FK866) effectively inhibits nicotinamide phosphoribosyltransferase (NMPRTase; Nampt) with IC50 of 0.09 nM in a cell-free assay. Daporinad (FK866, APO866) triggers autophagy. Phase 1/2. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        J Neuroinflammation, 2025, 22(1):113
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Commun Signal, 2025, 23(1):348
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        PLoS Pathog, 2025, 21(5):e1013163
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S8244 | 
                                    
                                        
                                        
                                            Etomoxir sodium salt
                                        
                                     | 
                                    Etomoxir sodium salt ((R)-(+)-Etomoxir sodium salt) is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) on the outer face of the inner mitochondrial membrane. Etomoxir enhances palmitate-induced cell apoptosis. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        J Clin Invest, 2025, e190215
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Commun Signal, 2025, 23(1):206
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Discov, 2025, 11(1):21
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S1453 | 
                                    
                                        
                                        
                                            Tipifarnib
                                        
                                     | 
                                    Tipifarnib is a potent and specific farnesyltransferase (FTase) inhibitor with IC50 of 0.6 nM, its anti-proliferative effects are most prominent in H-ras or N-ras mutant cells. Phase 3.  | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Sci Rep, 2025, 15(1):6832
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        PLoS One, 2025, 20(9):e0331440
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Rep, 2023, 42(9):113098
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S2797 | 
                                    
                                        
                                        
                                            Lonafarnib (SCH66336)
                                        
                                     | 
                                    Lonafarnib (SCH66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM in cell-free assays, respectively. Phase 3. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        iScience, 2025, 28(2):111864
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Sci Rep, 2025, 15(1):34331
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        PLoS One, 2025, 20(9):e0331440
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S7465 | 
                                    
                                        
                                        
                                            FTI 277 HCl
                                        
                                     | 
                                    FTI 277 HCl is a potent and selective farnesyltransferase (FTase) inhibitor with IC50 of 500 pM, about 100-fold selectivity over the closely related GGTase I. FTI 277 HCl inhibits cell growth and induces apoptosis. FTI 277 HCl is effective in clearing HDV viremia. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        EMBO J, 2025, 44(4):1185-1219
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        PLoS One, 2025, 20(9):e0331440
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cancer Res, 2023, 83(13):2248-2261
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S7466 | 
                                    
                                        
                                        
                                            GGTI 298 TFA salt
                                        
                                     | 
                                    GGTI 298 is a geranylgeranyltransferase I inhibitor with ability to arrest human tumor cells in the G1 phase of the cell cycle and induce apoptosis. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        bioRxiv, 2024, 10.1101/2024.01.16.575899
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Nat Commun, 2023, 14(1):3251
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Struct Funct, 2021, 46(1):1-9
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4989 | 
                                    
                                        
                                        
                                            AOA (Aminooxyacetic acid) hemihydrochloride
                                        
                                     | 
                                    AOA (Aminooxyacetic acid) hemihydrochloride is an inhibitor of aminobutyrate aminotransferase involved in amino acid and polyamine metabolism. AOA hemihydrochloride is also a CBS (cystathionine β-synthase) inhibitor. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Clin Mol Hepatol, 2025, 10.3350/cmh.2024.0694
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Pathogens, 2025, 14(5)439
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        bioRxiv, 2025, 2025.07.23.666333
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S8608 | 
                                    
                                        
                                        
                                            ADOX (Adenosine Dialdehyde)
                                        
                                     | 
                                    ADOX (Adenosine Dialdehyde) is an adenosine analog and S-adenosylmethionine-dependent methyltransferase inhibitor with an IC50 of 40 nM. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Nat Commun, 2024, 15(1):8971
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        EMBO J, 2023, e114558.
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        PLoS Biol, 2022, 20(2):e3001535
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S3021 | 
                                    
                                        
                                        
                                            Rimonabant (SR141716)
                                        
                                     | 
                                    Rimonabant (SR141716) is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane. Rimonabant is also a dual inhibitor of acyl CoA:cholesterol acyltransferases(ACAT) 1 and 2 and inhibits mycobacterial MmpL3. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Biol Pharm Bull, 2025, 48(6):769-781
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Toxicol Lett, 2023, 374:48-56
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Int J Biol Sci, 2022, 18(4):1401-1414
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S9870 | 
                                    
                                        
                                        
                                            STM2457
                                        
                                     | 
                                    STM2457 is a highly potent and selective first-in-class catalytic inhibitor of RNA Methyltransferase METTL3 with an IC50  of 16.9 nM. STM2457 is highly specific for METTL3 and showed no inhibition of other RNA methyltransferases. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Nat Commun, 2025, 16(1):4457
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Rep, 2025, S2211-1247(25)01101-5
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Virol, 2025, e0228424.
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S7894 | 
                                    
                                        
                                        
                                            Tunicamycin
                                        
                                     | 
                                    Tunicamycin, an antibiotic, can potently inhibit the N-linked glycosylation (NLG) by competitively inhibiting UDP-GlcNAc-dolichol-phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) activity and can target several types of tumors by reducing angiogenesis, inhibiting colony formation, and enhancing TRAIL-induced apoptosis. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Proc Natl Acad Sci U S A, 2025, 122(22):e2505975122
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Rep, 2025, 44(5):115686
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Eur Endod J, 2024, 9(4):335-343
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4589 | 
                                    
                                        
                                        
                                            Amodiaquine dihydrochloride dihydrate
                                        
                                     | 
                                    Amodiaquine is a potent, non-competitive inhibitor of histamine N-methyl transferase with estimated Ki of 18.6 nM. It is also used as an antimalarial and anti-inflammatory agent. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Differ, 2023, 10.1038/s41418-023-01167-4
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Nat Biomed Eng, 2021, 10.1038/s41551-021-00718-9
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Med Chem, 2020, 31
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S8910 | 
                                    
                                        
                                        
                                            OSMI-4
                                        
                                     | 
                                    OSMI-4 is an inhibitor of O-linked N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) with EC50 of 3 μM in cells. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Mol Cell, 2025, 85(7):1411-1425.e8
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Proc Natl Acad Sci U S A, 2025, 122(32):e2502687122
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Neoplasia, 2025, 62:101142
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S2674 | 
                                    
                                        
                                        
                                            A922500
                                        
                                     | 
                                    A922500 (DGAT-1 Inhibitor 4a) is an inhibitor for human and mouse DGAT-1 with IC50 of 7 nM and 24 nM, respectively, good selectivity over related acyltransferases, hERG, and a panel of anti-targets. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Discov, 2025, 11(1):21
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Nature, 2023, 621(7977):171-178
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Nature, 2023, 621(7977):171-178
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4021 | 
                                    
                                        
                                        
                                            Tolcapone
                                        
                                     | 
                                    Tolcapone (Ro 40-7592) is a selective, potent and reversible of catechol-O-methyl transferase (COMT) inhibitor with Ki of 30 nM. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        FASEB J, 2022, 36(7):e22399
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Viruses, 2021, 13(8)1533
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Front Bioinform, 2021, 1:710591
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4743 | 
                                    
                                        
                                        
                                            Wogonin
                                        
                                     | 
                                    Wogonin (Vogonin), a natural and biologically-active flavonoid found in plants, is an inhibitor of CDK9 and does not inhibit CDK2, CDK4 and CDK6 at doses that inhibit CDK9 activity; Also inhibits N-acetyltransferase. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Rep Med, 2025, S2666-3791(25)00231-9
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cancers -Basel, 2022, 14-174200
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Surg Res, 2021, 263:236-244
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | E0081 | 
                                    
                                        
                                        
                                            FIDAS-3
                                        
                                     | 
                                    FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for methionine sadenosyltransferase 2A (MAT2A) binding . FIDAS-3 has anticancer activities by inhibiting the expression of oncogenes. FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for MAT2A. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Dis, 2023, 14(8):525
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Dis, 2023, 14(8):525
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S9954 | 
                                    
                                        
                                        
                                            SGN-2FF
                                        
                                     | 
                                    SGN‐2FF (2-fluorofucose) is an orally bioavailable small‐molecule inhibitor of fucosyltransferase that demonstrated encouraging preclinical antitumor activity in mouse models. 
 | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Aging Dis, 2023, 14(5):1927-1944
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Aging Dis, 2023, 14(5):1927-1944
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S7192 | 
                                    
                                        
                                        
                                            PF-04620110
                                        
                                     | 
                                    PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Rep, 2025, 44(8):116100
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Commun Biol, 2025, 8(1):1169
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Pharm Biomed Anal, 2019, 170:176-186
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E1017 | 
                                    
                                        
                                        
                                            ERG240
                                        
                                     | 
                                    ERG240, a selective inhibitor of branched-chain aminotransferase 1 (BCAT1) with an IC50 of 0.1-1nM, leads to decreased oxygen consumption and glycolysis through the down regulation of IRG1 expression, which leads to decrease itaconate production in human macrophages. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Adv Sci (Weinh), 2023, 10(13):e2206439
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E0120 | 
                                    
                                        
                                        
                                            2-BP (2-Bromohexadecanoic acid)
                                        
                                     | 
                                    2-BP (2-Bromohexadecanoic acid) is a nonmetabolisable analogue of palmitate and acts as a palmitoylation inhibitor, which inhibits multiple palmitoyl-acyl transferase (PAT) activity towards MyrGCK(NBD) and FarnCNRas(NBD) with identical IC50s of approx. 4 µM. 2-Bromohexadecanoic acid can directly and irreversibly inhibit the palmitoyltransferase activity of all DHHC (Asp-His-His-Cys) proteins. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Nat Commun, 2025, 16(1):1762
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Dis, 2025, 16(1):17
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Free Radic Biol Med, 2025, 231:120-135
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S9835 | 
                                    
                                        
                                        
                                            OSMI-1
                                        
                                     | 
                                    OSMI-1 is a cell-permeable O-GlcNAc transferase (OGT) inhibitor with IC50 of 2.7 μM for full length human OGT (ncOGT). | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Nat Commun, 2025, 16(1):1274
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Dis, 2024, 15(4):244
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Commun Biol, 2024, 7(1):1530
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | F2228 | 
                                    
                                        
                                            
                                                Glutamine Synthetase Antibody [L12L23]
                                            
                                        
                                        
                                     | 
                                    Gl Syn,Glutamine Synthetase | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | F2925New | 
                                    
                                        
                                            
                                                ACAT1 Antibody [L1D14]
                                            
                                        
                                        
                                     | 
                                     | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | F2782New | 
                                    
                                        
                                            
                                                FDFT1 Antibody [H17C4]
                                            
                                        
                                        
                                     | 
                                     | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Ecotoxicol Environ Saf, 2025, 300:118459
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S2994 | 
                                    
                                        
                                        
                                            DL-Homocysteine
                                        
                                     | 
                                    DL-Homocysteine is a weak neurotoxin that affects the production of kynurenic acid (KYNA) in the brain. DL-Homocysteine inhibits the activity of both KYNA biosynthetic enzymes, kynurenine aminotransferases (KATs) I and II.  | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E1029 | 
                                    
                                        
                                        
                                            Miglustat
                                        
                                     | 
                                    Miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) is an orally administered ceramide glucosyltransferase inhibitor which prevents the lysosomal accumulation of glucocerebroside. 
 | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S9231 | 
                                    
                                        
                                        
                                            Schisanhenol
                                        
                                     | 
                                    Schisanhenol (Gomisin K3) is a compound derived from the fruit of a traditional Chinese herb Schisandra rubriflora, exhibiting strong inhibition toward UGT2B7. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Exploratory Research and Hypothesis in Medicine, 2023, 10.14218/ERHM.2023.00054
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S0970 | 
                                    
                                        
                                        
                                            Curzerene
                                        
                                     | 
                                    Curzerene, a sesquiterpene isolated from the rhizome of Curculigo orchioides Gaertn with anti-cancer activity, inhibits glutathione S-transferase A1 (GSTA1) mRNA and protein expression and induces cell apoptosis. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S9698 | 
                                    
                                        
                                        
                                            Ezatiostat
                                        
                                     | 
                                    Ezatiostat, a tripeptide analog of glutathione, is a peptidomimetic inhibitor of Glutathione S-transferase P1-1 (GSTP1-1). Ezatiostat activates c-Jun NH2 terminal kinase (JNK1) and ERK1/ERK2 and induces apoptosis. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S5336 | 
                                    
                                        
                                        
                                            Hecogenin
                                        
                                     | 
                                    Hecogenin (Hocogenin), a steroid saponin isolated from Agave sisalana, is a potent and highly selective inhibitor of UGT1A4 with an IC50 value of 1.5 μM. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S3945 | 
                                    
                                        
                                        
                                            L-Cycloserine
                                        
                                     | 
                                    L-Cycloserine (Levcycloserine, Levcicloserina, Levcycloserinum, (-)-Cycloserine, (S)-Cycloserine) is a potent inhibitor of the sphingolipid pathway via inhibiting 3-ketodihydrosphingosine synthetase. It also inhibits HIV-1 cytopathic effects, replication, and infectivity. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cancers (Basel), 2024, 16(23)3973
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E0405 | 
                                    
                                        
                                        
                                            L002 (NSC764414)
                                        
                                     | 
                                    L002 (NSC764414) is a potent, cell permeable, reversible and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 μM. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S5449 | 
                                    
                                        
                                        
                                            3-Methoxybenzamide
                                        
                                     | 
                                    3-Methoxybenzamide (3-MBA) is a competitive inhibitor of poly(ADP-ribose) synthetase with Ki values of less than 2 μM and also inhibits ADP-ribosyltransferase (ADPRT) | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S0359 | 
                                    
                                        
                                        
                                            T863 (DGAT-3)
                                        
                                     | 
                                    T863 (DGAT-3) is a potent, selective and orally active inhibitor of Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) tht acts on the acyl-CoA binding site of DGAT1 and inhibits DGAT1-mediated triacylglycerol formation in cells. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        J Virol, 2024, 98(11):e0110324
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Cell Sci, 2024, 137(20)jcs262162
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E4639 | 
                                    
                                        
                                        
                                            FIDAS-5
                                        
                                     | 
                                    FIDAS-5 is a potent and orally active inhibitor of methionine S-adenosyltransferase 2A (MAT2A) with an IC50 value of 2.1 μM, respectively. FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-5 also demonstrates anticancer activity. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4189 | 
                                    
                                        
                                        
                                            Cyclandelate
                                        
                                     | 
                                    Cyclandelate (BS 572,3,5,5-Trimethylcyclohexyl mandelate) is an effective inhibitor of rat hepatic acycloenzyme A: cholesterol acyltransferase (ACAT) with IC50 of 80 μM.  | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S7467 | 
                                    
                                        
                                        
                                            LB42708
                                        
                                     | 
                                    LB42708 is an orally active farnesyltransferase (FTase) inhibitor with IC50 of 0.8, 1.2, and 2.0 nM toward H-ras, N-ras, and K-ras, respectively. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cancer Res Commun, 2024, 10.1158/2767-9764.CRC-24-0221
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S5166 | 
                                    
                                        
                                        
                                            Benzoyleneurea
                                        
                                     | 
                                    Benzoyleneurea (2,4-Dihydroxyquinazoline, Quinazolinedione, Quinazoline-2,4-diol) scaffold is used in the synthesis of novel protein geranylgeranyltransferase-I inhibitors. Benzoyleneurea possesses anti-bacterial activity.  | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E6008New | 
                                    
                                        
                                        
                                            Miglustat hydrochloride
                                        
                                     | 
                                    Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an effective, reversible, and non-toxic iminosugar and an inhibitor of ceramide-specific glucosyl transferase and β-glucosidase 2, with an IC50 of 32 μM and 81 μM, respectively. It is used in the treatment and research of dyslipidosis-related disorders, including GM1 gangliosidosis, Gaucher type I, Tay-Sachs disease, and Niemann-Pick type C disease (NPCD). | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S6886 | 
                                    
                                        
                                        
                                            1-Aminobenzotriazole
                                        
                                     | 
                                    1-Aminobenzotriazole (ABT, 3-Aminobenzotriazole, 1-Benzotriazolylamine, NSC 114498, NSC 656987) is a nonselective and irreversible inhibitor of cytochrome P450 (CYP) enzymes. 1-Aminobenzotriazole is also a substrate and inhibitor of N-acetyltransferase (NAT). | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4280 | 
                                    
                                        
                                        
                                            Meclofenoxate (Centrophenoxine) HCl
                                        
                                     | 
                                    Meclofenoxate (Centrophenoxine) HCl is an anti-aging drug used to treat the symptoms of senile dementia and Alzheimer's disease, and also inhibits the activity of cholinephosphotransferase. 
 | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S6392 | 
                                    
                                        
                                        
                                            SHIN1(RZ-2994)
                                        
                                     | 
                                    SHIN1 (RZ-2994) is an inhibitor of SHMT1/2 (human serine hydroxymethyltransferase 1 and 2) with IC50 values of 5 and 13 nM, respectively, in in vitro assay. SHIN1 hinders cell growth by gradually reducing purine levels. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cancers (Basel), 2024, 16(21)3576
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                        
                    
                    
                        
                        
                            
                                
                                    
                                        | S2799 | 
                                        
                                            
                                            Daporinad (FK866)
                                                    
                                         | 
                                        Daporinad (FK866) effectively inhibits nicotinamide phosphoribosyltransferase (NMPRTase; Nampt) with IC50 of 0.09 nM in a cell-free assay. Daporinad (FK866, APO866) triggers autophagy. Phase 1/2. | 
                                        
                                            
                                                
                                                    
                                                        - J Neuroinflammation, 2025, 22(1):113
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Commun Signal, 2025, 23(1):348
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - PLoS Pathog, 2025, 21(5):e1013163
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S8244 | 
                                        
                                            
                                            Etomoxir sodium salt
                                                    
                                         | 
                                        Etomoxir sodium salt ((R)-(+)-Etomoxir sodium salt) is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) on the outer face of the inner mitochondrial membrane. Etomoxir enhances palmitate-induced cell apoptosis. | 
                                        
                                            
                                                
                                                    
                                                        - J Clin Invest, 2025, e190215
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Commun Signal, 2025, 23(1):206
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Death Discov, 2025, 11(1):21
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S1453 | 
                                        
                                            
                                            Tipifarnib
                                                    
                                         | 
                                        Tipifarnib is a potent and specific farnesyltransferase (FTase) inhibitor with IC50 of 0.6 nM, its anti-proliferative effects are most prominent in H-ras or N-ras mutant cells. Phase 3.  | 
                                        
                                            
                                                
                                                    
                                                        - Sci Rep, 2025, 15(1):6832
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - PLoS One, 2025, 20(9):e0331440
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Rep, 2023, 42(9):113098
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S2797 | 
                                        
                                            
                                            Lonafarnib (SCH66336)
                                                    
                                         | 
                                        Lonafarnib (SCH66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM in cell-free assays, respectively. Phase 3. | 
                                        
                                            
                                                
                                                    
                                                        - iScience, 2025, 28(2):111864
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Sci Rep, 2025, 15(1):34331
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - PLoS One, 2025, 20(9):e0331440
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S7465 | 
                                        
                                            
                                            FTI 277 HCl
                                                    
                                         | 
                                        FTI 277 HCl is a potent and selective farnesyltransferase (FTase) inhibitor with IC50 of 500 pM, about 100-fold selectivity over the closely related GGTase I. FTI 277 HCl inhibits cell growth and induces apoptosis. FTI 277 HCl is effective in clearing HDV viremia. | 
                                        
                                            
                                                
                                                    
                                                        - EMBO J, 2025, 44(4):1185-1219
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - PLoS One, 2025, 20(9):e0331440
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cancer Res, 2023, 83(13):2248-2261
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S7466 | 
                                        
                                            
                                            GGTI 298 TFA salt
                                                    
                                         | 
                                        GGTI 298 is a geranylgeranyltransferase I inhibitor with ability to arrest human tumor cells in the G1 phase of the cell cycle and induce apoptosis. | 
                                        
                                            
                                                
                                                    
                                                        - bioRxiv, 2024, 10.1101/2024.01.16.575899
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Nat Commun, 2023, 14(1):3251
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Struct Funct, 2021, 46(1):1-9
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4989 | 
                                        
                                            
                                            AOA (Aminooxyacetic acid) hemihydrochloride
                                                    
                                         | 
                                        AOA (Aminooxyacetic acid) hemihydrochloride is an inhibitor of aminobutyrate aminotransferase involved in amino acid and polyamine metabolism. AOA hemihydrochloride is also a CBS (cystathionine β-synthase) inhibitor. | 
                                        
                                            
                                                
                                                    
                                                        - Clin Mol Hepatol, 2025, 10.3350/cmh.2024.0694
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Pathogens, 2025, 14(5)439
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - bioRxiv, 2025, 2025.07.23.666333
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S8608 | 
                                        
                                            
                                            ADOX (Adenosine Dialdehyde)
                                                    
                                         | 
                                        ADOX (Adenosine Dialdehyde) is an adenosine analog and S-adenosylmethionine-dependent methyltransferase inhibitor with an IC50 of 40 nM. | 
                                        
                                            
                                                
                                                    
                                                        - Nat Commun, 2024, 15(1):8971
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - EMBO J, 2023, e114558.
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - PLoS Biol, 2022, 20(2):e3001535
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S3021 | 
                                        
                                            
                                            Rimonabant (SR141716)
                                                    
                                         | 
                                        Rimonabant (SR141716) is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane. Rimonabant is also a dual inhibitor of acyl CoA:cholesterol acyltransferases(ACAT) 1 and 2 and inhibits mycobacterial MmpL3. | 
                                        
                                            
                                                
                                                    
                                                        - Biol Pharm Bull, 2025, 48(6):769-781
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Toxicol Lett, 2023, 374:48-56
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Int J Biol Sci, 2022, 18(4):1401-1414
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S9870 | 
                                        
                                            
                                            STM2457
                                                    
                                         | 
                                        STM2457 is a highly potent and selective first-in-class catalytic inhibitor of RNA Methyltransferase METTL3 with an IC50  of 16.9 nM. STM2457 is highly specific for METTL3 and showed no inhibition of other RNA methyltransferases. | 
                                        
                                            
                                                
                                                    
                                                        - Nat Commun, 2025, 16(1):4457
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Rep, 2025, S2211-1247(25)01101-5
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Virol, 2025, e0228424.
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S7894 | 
                                        
                                            
                                            Tunicamycin
                                                    
                                         | 
                                        Tunicamycin, an antibiotic, can potently inhibit the N-linked glycosylation (NLG) by competitively inhibiting UDP-GlcNAc-dolichol-phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) activity and can target several types of tumors by reducing angiogenesis, inhibiting colony formation, and enhancing TRAIL-induced apoptosis. | 
                                        
                                            
                                                
                                                    
                                                        - Proc Natl Acad Sci U S A, 2025, 122(22):e2505975122
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Rep, 2025, 44(5):115686
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Eur Endod J, 2024, 9(4):335-343
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4589 | 
                                        
                                            
                                            Amodiaquine dihydrochloride dihydrate
                                                    
                                         | 
                                        Amodiaquine is a potent, non-competitive inhibitor of histamine N-methyl transferase with estimated Ki of 18.6 nM. It is also used as an antimalarial and anti-inflammatory agent. | 
                                        
                                            
                                                
                                                    
                                                        - Cell Death Differ, 2023, 10.1038/s41418-023-01167-4
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Nat Biomed Eng, 2021, 10.1038/s41551-021-00718-9
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Med Chem, 2020, 31
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S8910 | 
                                        
                                            
                                            OSMI-4
                                                    
                                         | 
                                        OSMI-4 is an inhibitor of O-linked N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) with EC50 of 3 μM in cells. | 
                                        
                                            
                                                
                                                    
                                                        - Mol Cell, 2025, 85(7):1411-1425.e8
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Proc Natl Acad Sci U S A, 2025, 122(32):e2502687122
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Neoplasia, 2025, 62:101142
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S2674 | 
                                        
                                            
                                            A922500
                                                    
                                         | 
                                        A922500 (DGAT-1 Inhibitor 4a) is an inhibitor for human and mouse DGAT-1 with IC50 of 7 nM and 24 nM, respectively, good selectivity over related acyltransferases, hERG, and a panel of anti-targets. | 
                                        
                                            
                                                
                                                    
                                                        - Cell Death Discov, 2025, 11(1):21
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Nature, 2023, 621(7977):171-178
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Nature, 2023, 621(7977):171-178
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4021 | 
                                        
                                            
                                            Tolcapone
                                                    
                                         | 
                                        Tolcapone (Ro 40-7592) is a selective, potent and reversible of catechol-O-methyl transferase (COMT) inhibitor with Ki of 30 nM. | 
                                        
                                            
                                                
                                                    
                                                        - FASEB J, 2022, 36(7):e22399
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Viruses, 2021, 13(8)1533
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Front Bioinform, 2021, 1:710591
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4743 | 
                                        
                                            
                                            Wogonin
                                                    
                                         | 
                                        Wogonin (Vogonin), a natural and biologically-active flavonoid found in plants, is an inhibitor of CDK9 and does not inhibit CDK2, CDK4 and CDK6 at doses that inhibit CDK9 activity; Also inhibits N-acetyltransferase. | 
                                        
                                            
                                                
                                                    
                                                        - Cell Rep Med, 2025, S2666-3791(25)00231-9
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cancers -Basel, 2022, 14-174200
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Surg Res, 2021, 263:236-244
 
                                                     
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | E0081 | 
                                        
                                            
                                            FIDAS-3
                                                    
                                         | 
                                        FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for methionine sadenosyltransferase 2A (MAT2A) binding . FIDAS-3 has anticancer activities by inhibiting the expression of oncogenes. FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for MAT2A. | 
                                        
                                            
                                                
                                                    
                                                        - Cell Death Dis, 2023, 14(8):525
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Death Dis, 2023, 14(8):525
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S9954 | 
                                        
                                            
                                            SGN-2FF
                                                    
                                         | 
                                        SGN‐2FF (2-fluorofucose) is an orally bioavailable small‐molecule inhibitor of fucosyltransferase that demonstrated encouraging preclinical antitumor activity in mouse models. 
 | 
                                        
                                            
                                                
                                                    
                                                        - Aging Dis, 2023, 14(5):1927-1944
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Aging Dis, 2023, 14(5):1927-1944
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S7192 | 
                                        
                                            
                                            PF-04620110
                                                    
                                         | 
                                        PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM. | 
                                        
                                            
                                                
                                                    
                                                        - Cell Rep, 2025, 44(8):116100
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Commun Biol, 2025, 8(1):1169
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Pharm Biomed Anal, 2019, 170:176-186
 
                                                     
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E1017 | 
                                        
                                            
                                            ERG240
                                                    
                                         | 
                                        ERG240, a selective inhibitor of branched-chain aminotransferase 1 (BCAT1) with an IC50 of 0.1-1nM, leads to decreased oxygen consumption and glycolysis through the down regulation of IRG1 expression, which leads to decrease itaconate production in human macrophages. | 
                                        
                                            
                                                
                                                    
                                                        - Adv Sci (Weinh), 2023, 10(13):e2206439
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E0120 | 
                                        
                                            
                                            2-BP (2-Bromohexadecanoic acid)
                                                    
                                         | 
                                        2-BP (2-Bromohexadecanoic acid) is a nonmetabolisable analogue of palmitate and acts as a palmitoylation inhibitor, which inhibits multiple palmitoyl-acyl transferase (PAT) activity towards MyrGCK(NBD) and FarnCNRas(NBD) with identical IC50s of approx. 4 µM. 2-Bromohexadecanoic acid can directly and irreversibly inhibit the palmitoyltransferase activity of all DHHC (Asp-His-His-Cys) proteins. | 
                                        
                                            
                                                
                                                    
                                                        - Nat Commun, 2025, 16(1):1762
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Death Dis, 2025, 16(1):17
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Free Radic Biol Med, 2025, 231:120-135
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S9835 | 
                                        
                                            
                                            OSMI-1
                                                    
                                         | 
                                        OSMI-1 is a cell-permeable O-GlcNAc transferase (OGT) inhibitor with IC50 of 2.7 μM for full length human OGT (ncOGT). | 
                                        
                                            
                                                
                                                    
                                                        - Nat Commun, 2025, 16(1):1274
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Death Dis, 2024, 15(4):244
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Commun Biol, 2024, 7(1):1530
 
                                                     
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S2994 | 
                                        
                                            
                                            DL-Homocysteine
                                                    
                                         | 
                                        DL-Homocysteine is a weak neurotoxin that affects the production of kynurenic acid (KYNA) in the brain. DL-Homocysteine inhibits the activity of both KYNA biosynthetic enzymes, kynurenine aminotransferases (KATs) I and II.  | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E1029 | 
                                        
                                            
                                            Miglustat
                                                    
                                         | 
                                        Miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) is an orally administered ceramide glucosyltransferase inhibitor which prevents the lysosomal accumulation of glucocerebroside. 
 | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S9231 | 
                                        
                                            
                                            Schisanhenol
                                                    
                                         | 
                                        Schisanhenol (Gomisin K3) is a compound derived from the fruit of a traditional Chinese herb Schisandra rubriflora, exhibiting strong inhibition toward UGT2B7. | 
                                        
                                            
                                                
                                                    
                                                        - Exploratory Research and Hypothesis in Medicine, 2023, 10.14218/ERHM.2023.00054
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S0970 | 
                                        
                                            
                                            Curzerene
                                                    
                                         | 
                                        Curzerene, a sesquiterpene isolated from the rhizome of Curculigo orchioides Gaertn with anti-cancer activity, inhibits glutathione S-transferase A1 (GSTA1) mRNA and protein expression and induces cell apoptosis. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S9698 | 
                                        
                                            
                                            Ezatiostat
                                                    
                                         | 
                                        Ezatiostat, a tripeptide analog of glutathione, is a peptidomimetic inhibitor of Glutathione S-transferase P1-1 (GSTP1-1). Ezatiostat activates c-Jun NH2 terminal kinase (JNK1) and ERK1/ERK2 and induces apoptosis. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S5336 | 
                                        
                                            
                                            Hecogenin
                                                    
                                         | 
                                        Hecogenin (Hocogenin), a steroid saponin isolated from Agave sisalana, is a potent and highly selective inhibitor of UGT1A4 with an IC50 value of 1.5 μM. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S3945 | 
                                        
                                            
                                            L-Cycloserine
                                                    
                                         | 
                                        L-Cycloserine (Levcycloserine, Levcicloserina, Levcycloserinum, (-)-Cycloserine, (S)-Cycloserine) is a potent inhibitor of the sphingolipid pathway via inhibiting 3-ketodihydrosphingosine synthetase. It also inhibits HIV-1 cytopathic effects, replication, and infectivity. | 
                                        
                                            
                                                
                                                    
                                                        - Cancers (Basel), 2024, 16(23)3973
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E0405 | 
                                        
                                            
                                            L002 (NSC764414)
                                                    
                                         | 
                                        L002 (NSC764414) is a potent, cell permeable, reversible and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 μM. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S5449 | 
                                        
                                            
                                            3-Methoxybenzamide
                                                    
                                         | 
                                        3-Methoxybenzamide (3-MBA) is a competitive inhibitor of poly(ADP-ribose) synthetase with Ki values of less than 2 μM and also inhibits ADP-ribosyltransferase (ADPRT) | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S0359 | 
                                        
                                            
                                            T863 (DGAT-3)
                                                    
                                         | 
                                        T863 (DGAT-3) is a potent, selective and orally active inhibitor of Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) tht acts on the acyl-CoA binding site of DGAT1 and inhibits DGAT1-mediated triacylglycerol formation in cells. | 
                                        
                                            
                                                
                                                    
                                                        - J Virol, 2024, 98(11):e0110324
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Cell Sci, 2024, 137(20)jcs262162
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E4639 | 
                                        
                                            
                                            FIDAS-5
                                                    
                                         | 
                                        FIDAS-5 is a potent and orally active inhibitor of methionine S-adenosyltransferase 2A (MAT2A) with an IC50 value of 2.1 μM, respectively. FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-5 also demonstrates anticancer activity. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4189 | 
                                        
                                            
                                            Cyclandelate
                                                    
                                         | 
                                        Cyclandelate (BS 572,3,5,5-Trimethylcyclohexyl mandelate) is an effective inhibitor of rat hepatic acycloenzyme A: cholesterol acyltransferase (ACAT) with IC50 of 80 μM.  | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S7467 | 
                                        
                                            
                                            LB42708
                                                    
                                         | 
                                        LB42708 is an orally active farnesyltransferase (FTase) inhibitor with IC50 of 0.8, 1.2, and 2.0 nM toward H-ras, N-ras, and K-ras, respectively. | 
                                        
                                            
                                                
                                                    
                                                        - Cancer Res Commun, 2024, 10.1158/2767-9764.CRC-24-0221
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S5166 | 
                                        
                                            
                                            Benzoyleneurea
                                                    
                                         | 
                                        Benzoyleneurea (2,4-Dihydroxyquinazoline, Quinazolinedione, Quinazoline-2,4-diol) scaffold is used in the synthesis of novel protein geranylgeranyltransferase-I inhibitors. Benzoyleneurea possesses anti-bacterial activity.  | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E6008New | 
                                        
                                            
                                            Miglustat hydrochloride
                                                    
                                         | 
                                        Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an effective, reversible, and non-toxic iminosugar and an inhibitor of ceramide-specific glucosyl transferase and β-glucosidase 2, with an IC50 of 32 μM and 81 μM, respectively. It is used in the treatment and research of dyslipidosis-related disorders, including GM1 gangliosidosis, Gaucher type I, Tay-Sachs disease, and Niemann-Pick type C disease (NPCD). | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S6886 | 
                                        
                                            
                                            1-Aminobenzotriazole
                                                    
                                         | 
                                        1-Aminobenzotriazole (ABT, 3-Aminobenzotriazole, 1-Benzotriazolylamine, NSC 114498, NSC 656987) is a nonselective and irreversible inhibitor of cytochrome P450 (CYP) enzymes. 1-Aminobenzotriazole is also a substrate and inhibitor of N-acetyltransferase (NAT). | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4280 | 
                                        
                                            
                                            Meclofenoxate (Centrophenoxine) HCl
                                                    
                                         | 
                                        Meclofenoxate (Centrophenoxine) HCl is an anti-aging drug used to treat the symptoms of senile dementia and Alzheimer's disease, and also inhibits the activity of cholinephosphotransferase. 
 | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S6392 | 
                                        
                                            
                                            SHIN1(RZ-2994)
                                                    
                                         | 
                                        SHIN1 (RZ-2994) is an inhibitor of SHMT1/2 (human serine hydroxymethyltransferase 1 and 2) with IC50 values of 5 and 13 nM, respectively, in in vitro assay. SHIN1 hinders cell growth by gradually reducing purine levels. | 
                                        
                                            
                                                
                                                    
                                                        - Cancers (Basel), 2024, 16(21)3576
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         |